AlzBiomarker
Control vs Alzheimer's Disease: sTREM2 (CSF)
TREM2 is a microglial transmembrane protein that is proteolytically processed to release a soluble fragment (sTREM2). Meta-analysis showed that the level of sTREM2 in cerebrospinal fluid of control subjects was about three-quarters that of people with Alzheimer's disease (effect size = 0.761, p <0.0001).
Loading data...